Showing results (1261-1270 of 1,308) with videos related to
Sort By:
Pageof 131
Molecular Therapy. Methods & Clinical Development|September 23, 2024
Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamstersLevi Tamming, Diana Duque, Jegarubee Bavananthasivam, et al.Cell|November 7, 2015
Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems SerologyAmy W Chung, Manu P Kumar, Kelly B Arnold, et al.Journal of AIDS & Clinical Research|November 21, 2015
Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive IndividualsJonathan D Fuchs, Pierre-Alexandre Bart, Nicole Frahm, et al.Nature Biotechnology|May 26, 2015
COMPASS identifies T-cell subsets correlated with clinical outcomesLin Lin, Greg Finak, Kevin Ushey, et al.Molecular Therapy. Methods & Clinical Development|January 6, 2025
Erratum: Lipid nanoparticle encapsulation of a Delta spike-CD40L DNA vaccine improves effectiveness against Omicron challenge in Syrian hamstersLevi Tamming, Diana Duque, Anh Tran, et al.Journal of Virology|November 24, 2006
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypesXu G Yu, Mathias Lichterfeld, Senica Chetty, et al.Springerplus|August 26, 2015
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patientsRuth S Weinberg, Marcelo O Grecco, Gimena S Ferro, et al.Clinical and Vaccine Immunology : CVI|September 22, 2017
DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8+ T-Cell Responses by Interleukin-12 Plasmid DNAShuying S Li, Nidhi K Kochar, Marnie Elizaga, et al.The Journal of Infectious Diseases|February 16, 2017
Higher T-Cell Responses Induced by DNA/rAd5 HIV-1 Preventive Vaccine Are Associated With Lower HIV-1 Infection Risk in an Efficacy TrialHolly E Janes, Kristen W Cohen, Nicole Frahm, et al.Nature Immunology|December 22, 2005
Control of human immunodeficiency virus replication by cytotoxic T lymphocytes targeting subdominant epitopesNicole Frahm, Photini Kiepiela, Sharon Adams, et al.Pageof 131